Literature DB >> 9880292

Protease inhibitors in HIV infection. Lipodystrophy may be a consequence of prolonged survival.

N Buss, F Duff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9880292      PMCID： PMC1114581     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Authors:  A Carr; K Samaras; D J Chisholm; D A Cooper
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

2.  "Buffalo hump" in men with HIV-1 infection.

Authors:  J C Lo; K Mulligan; V W Tai; H Algren; M Schambelan
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

3.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

4.  Disorders of fat distribution in HIV infection.

Authors:  A J Shaw; K A McLean; B A Evans
Journal:  Int J STD AIDS       Date:  1998-10       Impact factor: 1.359
  4 in total
  1 in total

Review 1.  Lipodystrophy syndrome in patients with HIV infection: quality of life issues.

Authors:  E Martínez; M A Garcia-Viejo; L Blanch; J M Gatell
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.